ClinConnect ClinConnect Logo
Search / Trial NCT05283382

Cannabidiol Effects on Learning and Anxiety

Launched by UNIVERSITY OF CONNECTICUT · Mar 7, 2022

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Social Anxiety Fear Conditioning Cannabidiol Electrodermal Response

ClinConnect Summary

This clinical trial is studying the effects of Cannabidiol (CBD) on reducing anxiety and fear in college students who experience high levels of social anxiety. The researchers want to see if taking CBD can help these individuals feel less fearful after being exposed to faces that they have been conditioned to associate with a negative experience, like a mild shock. Participants will be divided into two groups: one group will receive a single dose of CBD, while the other group will receive a placebo, which is a harmless substance that does not contain any active medication. The researchers will measure how quickly and effectively participants stop feeling fear when they see the faces again, using simple tests and questionnaires.

To be eligible for this trial, participants must be between 18 and 50 years old and show signs of social anxiety. However, people with certain health issues, those who have used CBD or cannabis products recently, or those who are pregnant or breastfeeding cannot participate. Everyone involved in the study will go through a fear conditioning task and have their responses monitored, helping researchers understand the potential benefits of CBD for anxiety. This trial is currently recruiting participants, so if you or someone you know might fit the criteria, it could be an opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18-50 years of age
  • Exclusion Criteria:
  • 1. Difficulties seeing a computer screen
  • 2. Anyone currently taking CBD within the last 24 hours.
  • 3. Anyone using any cannabis product within the last 24 hours.
  • 4. Heart problems or heart disease
  • 5. A neurological disorder such as epilepsy, stroke, multiple sclerosis, tumor, vascular malformations, aneurysm
  • 6. Are currently pregnant or breast-feeding

About University Of Connecticut

The University of Connecticut (UConn) is a leading academic institution committed to advancing health and science through innovative research and education. As a clinical trial sponsor, UConn leverages its extensive resources, including renowned faculty and state-of-the-art facilities, to conduct rigorous studies that contribute to medical knowledge and improve patient care. The university fosters a collaborative environment, engaging multidisciplinary teams to explore novel therapies and interventions across various health-related fields. UConn's dedication to ethical practices and compliance ensures the integrity and reliability of its clinical research, ultimately aiming to enhance health outcomes and address critical challenges in healthcare.

Locations

Storrs, Connecticut, United States

Storrs, Connecticut, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials